FLGT - Fulgent Genetics Inc. (FLGT) CEO Ming Hsieh on Q3 2021 Results - Earnings Call Transcript

Fulgent Genetics, Inc. (FLGT) Q3 2021 Earnings Conference Call November 9, 2021, 4:30 PM ET Company Participants Ming Hsieh – Chief Executive Officer Nicole Borsje – Investor Relations Paul Kim – Chief Financial Officer Larry Weiss – Chief Medical Officer Brandon Perthuis – Chief Commercial Officer Conference Call Participants Kevin DeGeeter – Oppenheimer Presentation Operator Good day and welcome to the Fulgent Genetics Third Quarter 2021 Earnings Conference Call. At this time, I would like to turn the conference over to Nicole Borsje, Investor Relations, please go ahead, ma'am. Nicole Borsje Great. Thanks. Good afternoon and welcome to the Fulgent Genetics, third quarter 2021 financial results conference call. On the call today are Ming Hsieh, Chief Executive Officer, Paul Kim, Chief Financial Officer, Dr. Larry Weiss, Chief Medical Officer, and Brandon Perthuis, Chief Commercial Officer. The Company's press release discussing its financial results is available in the Investor Relations section

For further details see:

Fulgent Genetics, Inc. (FLGT) CEO Ming Hsieh on Q3 2021 Results - Earnings Call Transcript